Department of Preventive Gerontology, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Aichi, Japan.
Department of Preventive Gerontology, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Aichi, Japan.
J Am Med Dir Assoc. 2021 Apr;22(4):846-852. doi: 10.1016/j.jamda.2020.10.036. Epub 2020 Nov 21.
The updated definition of sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP2) recommends both low muscle mass and quality to diagnose sarcopenia; concurrent poor physical performance is considered indicative of severe sarcopenia; however, the relationship between the revised definition and disability incidence among Japanese older adults is unclear. Therefore, we aimed to examine the associations between EWGSOP2-defined sarcopenia and disability incidence among community-dwelling older Japanese adults.
Nationwide study.
We included 4561 individuals aged ≥65 years and enrolled in the National Center for Geriatrics and Gerontology-Study of Geriatric Syndromes (NCGG-SGS).
Skeletal muscle mass was assessed using a bioimpedance analysis device; handgrip strength and walking speed were measured as physical performance indicators. We used the Asian Working Group for Sarcopenia cutoffs to define low muscle mass and poor physical performance. We stratified all participants into nonsarcopenia, sarcopenia, and severe sarcopenia groups. Disability incidence was prospectively determined over 49 months using data extracted from the Japanese long-term care insurance system.
The prevalence of sarcopenia and severe sarcopenia was 3.4% and 1.7%, respectively. Participants with any form of sarcopenia were at a higher risk of disability [hazard ratio (HR) 1.78, 95% confidence interval (CI) 1.27-2.49]. Although participants with severe sarcopenia showed a higher risk of disability (HR 2.00, 95% CI 1.32-3.02), there was no significant disability risk in the sarcopenia group (HR 1.54, 95% CI 0.97-2.46). Grip strength (HR 0.96, 95% CI 0.94-0.98) and walking speed (HR 0.19, 95% CI 0.12-0.30) negatively correlated with disability incidence.
Severe sarcopenia, involving low muscle mass and poor physical performance, might increase disability risk in older adults, as opposed to low muscle mass alone. Further studies are needed to determine whether sarcopenia without poor physical performance increases disability risk.
欧洲老年人肌肉减少症工作组(EWGSOP2)对肌肉减少症的定义进行了更新,建议将低肌肉量和低肌肉质量同时用于诊断肌肉减少症;并认为同时存在身体机能较差与严重肌肉减少症相关;然而,修订后的定义与日本老年人残疾发生率之间的关系尚不清楚。因此,我们旨在研究 EWGSOP2 定义的肌肉减少症与日本社区居住的老年成年人残疾发生率之间的关系。
全国性研究。
我们纳入了年龄≥65 岁并参加日本国家老年医学和老年学研究中心-老年综合征研究(NCGG-SGS)的 4561 名个体。
使用生物电阻抗分析设备评估骨骼肌质量;握力和步行速度作为身体机能指标进行测量。我们使用亚洲肌肉减少症工作组的切点来定义低肌肉量和身体机能较差。我们将所有参与者分为非肌肉减少症、肌肉减少症和严重肌肉减少症组。使用从日本长期护理保险系统中提取的数据,在 49 个月的时间内前瞻性地确定残疾发生率。
肌肉减少症和严重肌肉减少症的患病率分别为 3.4%和 1.7%。任何形式的肌肉减少症患者残疾风险较高(危险比[HR]1.78,95%置信区间[CI]1.27-2.49)。虽然严重肌肉减少症患者的残疾风险较高(HR 2.00,95%CI 1.32-3.02),但肌肉减少症患者的残疾风险无显著增加(HR 1.54,95%CI 0.97-2.46)。握力(HR 0.96,95%CI 0.94-0.98)和步行速度(HR 0.19,95%CI 0.12-0.30)与残疾发生率呈负相关。
严重肌肉减少症(涉及低肌肉量和身体机能较差)可能会增加老年人的残疾风险,而不仅仅是低肌肉量。需要进一步的研究来确定是否不伴有身体机能较差的肌肉减少症会增加残疾风险。